MENS
Jyong BiotechยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MENS Profile
Jyong Biotech Ltd.
A biotech company based in Taiwan focused on developing and commercializing innovative and differentiated botanical-derived new drugs for the treatment of urological diseases
Pharmaceutical
01/26/2018
06/17/2025
NASDAQ Stock Exchange
32
12-31
Common stock
23F-3, No. 95, Section 1, Xintai 5th Road, Xizhi District, New Taipei City, Taiwan, 221
--
Jyong Biotech Ltd., a Cayman Islands exempted company incorporated on January 26, 2018, conducts business primarily through a wholly-owned subsidiary in Taiwan, China. Jianyongsheng Technology began commercial operations in July 2002 through Health Ever Bio-Tech Co., Ltd., which has been wholly owned by Jyong Biotech Ltd. since August 2018. Jianyongbiotech is a science-driven biotechnology company headquartered in Taiwan, China, dedicated to the development and commercialization of innovative and differentiated new drugs (plant-derived), mainly focusing on the treatment of urinary system diseases, with an initial focus on the US, EU and Asian markets.
